Wenbin Shen

机构：Capital Medical University, Beijing Shijitan Hospital · ORCID：0000-0002-1201-6443

发表论文 105 篇 · 总被引 525 次 · h-index 11

代表论文

• A Salidroside‐Based Radiosensitizer Regulates the Nrf2/ROS Pathway for X‐Ray Activated Synergistic Cancer Precise Therapy (2025 · Advanced Materials · 被引 21)
• Integrated Single-Step Terahertz Metasensing for Simultaneous Detection Based on Exosomal Membrane Proteins Enables Pathological Typing of Gastric Cancer (2025 · Research · 被引 20)
• Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for stages III–IV, unresectable ovarian cancer: a single-arm, open-label, phase Ib/II study (2024 · BMC Medicine · 被引 9)
• Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355) (2025 · Frontiers in Immunology · 被引 3)
• Prognostic value of immunotrophic inflammatory markers in ESCC undergoing chemoradiotherapy combined with immunotherapy (2025 · Scientific Reports · 被引 3)
• Real-world study of first-line immunotherapy combined with chemoradiotherapy in esophageal squamous cell carcinoma (2025 · Scientific Reports · 被引 2)